Description:

SOUTHWEST ONCOLOGY GROUP S0347 ADVERSE EVENT FORM Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E1F2198E-7C5B-3F6A-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E1F2198E-7C5B-3F6A-E034-0003BA12F5E7

  1. 8/26/12 8/26/12 -
  2. 1/8/15 1/8/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
  4. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00103233 Toxicity - SOUTHWEST ONCOLOGY GROUP S0347 ADVERSE EVENT FORM - 2291400v3.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0347 ADVERSE EVENT FORM
    1. No Instruction available.
Header
Adverse Events
Were adverse events assessed during this time period?
CTC Adverse Event Term
Adverse Event Status Code (**)
Adverse Event Status Code (**)
CTC Adverse Event Attribution Code
CTC Adverse Event Attribution Code
Comments

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial